OPA3 and movement disorder: Missense biallelic OPA3 variants were first described in an Iraqi Jewish community to have infantile optic atrophy, movement disorder, spastic paraparesis, ataxia, seizures, and cognitive impairment, now known as Costeff syndrome[284].